Legacy Opioid Patient

MTD, Dose> 120MED, Benzo’s/Sedatives

H/O Addiction/Aberrant Behavior/Hep C

Continue Regimen with Surveillance

Harm Reduction: Taper, Conversion/

Buprenorphine

Referral to Addiction, Taper, Stop Therapy

Continue Regimen with Surveillance

YES NO YES NO

Sunday, December 13, 15